Genetic algorithm for the design of molecules with desired properties

No abstract is available for this paper.

• Publication year

  2002

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  2002-08-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1023/A:1021928016359PMID 12602950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug discovery today.

  2003cited by this paper
• Proteinlike behavior of a spin system near the transition between a ferromagnet and a spin glass.

  2001cited by this paper
• A genetic algorithm for the automated generation of small organic molecules: Drug design using an evolutionary algorithm

  2000cited by this paper
• Simulated molecular evolution in a full combinatorial library.

  2000cited by this paper
• De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks

  2000cited by this paper
• Synthetic inhibitors of thrombin and factor Xa: from bench to bedside.

  1999cited by this paper
• Foundations of Genetic Algorithms

  1997cited by this paper
• Optimizing doped libraries by using genetic algorithms

  1997cited by this paper
• Display of functional thrombin inhibitor hirudin on the surface of phage M13.

  1997cited by this paper
• Designing Molecules with Specific Properties from Intercommunicating Hybrid Systems

  1996cited by this paper
• Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks.

  1996cited by this paper
• A genetic algorithm for the automated generation of molecules within constraints

  1995cited by this paper
• PRO_LIGAND: An approach to de novo molecular design. 3. A genetic algorithm for structure refinement

  1995cited by this paper
• Optimierung der biologischen Aktivität von kombinatorischen Verbindungsbibliotheken durch einen genetischen Algorithmus

  1995cited by this paper
• The rational design of amino acid sequences by artificial neural networks and simulated molecular evolution: de novo design of an idealized leader peptidase cleavage site.

  1994cited by this paper
• Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.

  1994cited by this paper
• Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence

  1992cited by this paper
• Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

  1992cited by this paper
• Spontaneous generation of selectable variation in the brain

  1991cited by this paper
• The simultaneous multiple production of solution phase peptides; assessment of the geysen method of simultaneous peptide synthesis.

  1990cited by this paper
• Genetic Algorithms in Search Optimization and Machine Learning

  1988influential reference
• Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information

  1981cited by this paper
• The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle.

  1977cited by this paper
• A principle of natural self-organization

  1977cited by this paper
• Selforganization of matter and the evolution of biological macromolecules

  1971cited by this paper
• Tetrahedron

  1957cited by this paper

• Modeling chemical reactivity in complex systems: Insights from hybrid QM/MM MD simulations

  2026cites this paper
• Bioinformatics tools and experimental analysis combination for production of specific scFv against CD133

  2025cites this paper
• Reverse Designing the Wavelength-Specific Thermally Activation Delayed Fluorescent Molecules Using a Genetic Algorithm Coupled with Cheap QM Methods.

  2023cites this paper
• Computational Analysis of Topological Index-Based Entropies of Carbon Nanotube Y-Junctions

  2022cites this paper
• A molecular evolution algorithm for ligand design in DOCK

  2022cites this paper
• Autonome Entdeckung in den chemischen Wissenschaften, Teil I: Fortschritt

  2020cites this paper
• Autonomous discovery in the chemical sciences part I: Progress

  2020cites this paper
• New Data Structure for Computational Molecular Design with Atomic or Fragment Resolution

  2019cites this paper
• Linkers: The key elements for the creation of efficient nanotherapeutics

  2018cites this paper
• Chapter Four - Recent Advances of Microfluidics Technologies in the Field of Medicinal Chemistry

  2017cites this paper
• CLASSES OF GRAPHS HAVING EXTREMAL TOPOLOGICAL INDICES

  2016cites this paper
• Path-tables of trees: a survey and some new results

  2015cites this paper
• Active-learning strategies in computer-assisted drug discovery.

  2015cites this paper
• On the history of the connectivity index: from the connectivity index to the exact solution of the protein alignment problem$

  2015cites this paper
• Mathematical Analysis of a Series of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines: A Simple Way to Relate Quantum Similarity to Local Chemical Reactivity Using the Gaussian Orbitals Localized Theory

  2014cites this paper
• An in silico overview on the usefulness of tags and linkers in plant molecular pharming

  2014cites this paper
• Evolutionary Algorithm for Drug Discovery Interim Design Report

  2014cites this paper
• Development of a New De Novo Design Algorithm for Exploring Chemical Space

  2014cites this paper
• Structure-based de novo drug design

  2013cites this paper
• Optimization‐based framework for computer‐aided molecular design

  2013cites this paper
• Toward Development of Novel Peptide-Based Cancer Therapeutics: Computational Design and Experimental Evaluation

  2013cites this paper
• Analysis of the relationship between end-to-end distance and activity of single-chain antibody against colorectal carcinoma

  2012cites this paper
• The Research Progress of Bioinformatics-Led Design of Single-Chain Antibody Molecules

  2012cites this paper
• Multi-objective optimization methods in de novo drug design.

  2012cites this paper
• Molecular Evolution of a Peptide GPCR Ligand Driven by Artificial Neural Networks

  2012cites this paper
• Systematic generation of chemical structures for rational drug design based on QSAR models.

  2011cites this paper
• Bioinformatics-led design of single-chain antibody molecules targeting DNA sequences for retinoblastoma.

  2011cites this paper
• Advances in methods for therapeutic peptide discovery, design and development.

  2011cites this paper
• Computational Design and Selection of Optimal Organic Photovoltaic Materials

  2011cites this paper
• Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.

  2011cites this paper
• Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM)

  2011cites this paper
• Constructing a novel mortality prediction model with Bayes theorem and genetic algorithm

  2011cites this paper
• VitAL: Viterbi Algorithm for de novo Peptide Design

  2010cites this paper
• Inhibitor peptide design for NF-кB: Markov model & genetic algorithm

  2010cites this paper
• Study of proteome maps using partial ordering.

  2010cites this paper
• 11 2 Evolutionary Algorithms in Drug Design

  2010cites this paper
• De novo design: balancing novelty and confined chemical space

  2010cites this paper
• Genetic Algorithms, a Nature-Inspired Tool: A Survey of Applications in Materials Science and Related Fields: Part II

  2009cites this paper
• Design and optimization of a linker for fusion protein construction

  2009cites this paper
• A STUDY OF HYDROPHOBIC EFFECT ON THE PROTEIN FOLDING USING MONTE CARLO

  2009cites this paper
• Genetic Algorithms, a Nature-Inspired Tool: Survey of Applications in Materials Science and Related Fields

  2009cites this paper
• Topology Preserving Neural Networks for Peptide Design in Drug Discovery

  2009cites this paper
• A review on molecular topology: applying graph theory to drug discovery and design

  2009cites this paper
• Adaptation and self-organization in evolutionary algorithms

  2009cites this paper
• Structure of a novel thrombin inhibitor with an uncharged D-amino acid as P1 residue.

  2008cites this paper
• Cellulose-bound peptide arrays : preparation and applications 31

  2007cites this paper
• In Silico Design of Ligands Using Properties of Target Active Sites

  2007cites this paper
• Cellulose-bound Peptide Arrays: Preparation and Applications

  2007cites this paper
• Improving the efficiency of evolutionary de novo peptide design: Strategies for probing configuration and parameter settings

  2007cites this paper
• Evolutionary computation and multimodal search: A good combination to tackle molecular diversity in the field of peptide design

  2007cites this paper
• The Molecule Evoluator. An Interactive Evolutionary Algorithm for the Design of Drug-Like Molecules

  2006cites this paper
• A novel workflow for the inverse QSPR problem using multiobjective optimization

  2006cites this paper
• Properties of a genetic algorithm extended by a random self-learning operator and asymmetric mutations: A convergence study for a task of powder-pattern indexing

  2006cites this paper
• LigEvolver: A Tool for ligand formulation using genetic algorithm

  2006cites this paper
• Molecular quantum similarity using conceptual DFT descriptors

  2005cites this paper
• The molecule evoluator: an interactive evolutionary algorithm for designing drug molecules

  2005cites this paper
• A combinatorial approach toward the generation of ambiphilic peptide-based inhibitors of protein:geranylgeranyl transferase-1.

  2005cites this paper
• Thrombin inhibitors identified by computer-assisted multiparameter design.

  2005cites this paper
• ENPDA: an evolutionary structure-based de novo peptide design algorithm

  2005cites this paper
• NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.

  2005cites this paper
• Evolutionary Algorithms in Drug Design

  2005cites this paper
• Using data mining to improve mutation in a tool for molecular evolution

  2005cites this paper
• Active Site Driven Ligand Design: an Evolutionary Approach

  2005cites this paper
• Entwicklung von Substraten und Inhibitoren pharmakologisch relevanter Proteintargets

  2005cites this paper
• Computer-Aided Peptide Evolution for Virtual Drug Design

  2004cites this paper
• A Graph-Based Genetic Algorithm and Its Application to the Multiobjective Evolution of Median Molecules

  2004cites this paper
• Learning to Find Graph Pre-images

  2004cites this paper
• Sustainable Development and Chemistry

  2004cites this paper
• In silico selection of functional RNA molecules.

  2004cites this paper
• 4-regular Graphs without Cut-vertices Having the Same Path Layer Matrix

  2003cites this paper
• Cubic graphs without cut‐vertices having the same path layer matrix

  2001cites this paper
• Theory and Applications of Graphs Theory and Applications of Graphs

  year unknowncites this paper